A poliomyelitis that results in destruction located in motor neurons of central nervous system, has material basis in Human poliovirus 1, has material basis in Human poliovirus 2, or has material basi...
Comprehensive, easy-to-understand information about this condition
How we create this content →Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 9, 2026
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning paralytic poliomyelitis
Updated Feb 10, 2026
A recent study evaluates the safety of the inactivated poliomyelitis vaccine, contributing to ongoing research in vaccine safety. Findings may inform future vaccination strategies and public health policies.
Polio cases in Pakistan and Afghanistan decreased from January to September 2013 compared to the same period in 2012, according to the CDC. This progress highlights ongoing efforts to combat wild poliovirus in these regions.
The CDC highlights a new exhibition featuring Sebasti-o Salgado's photographs documenting the global effort to eradicate polio. This initiative aims to raise awareness about the disease and the ongoing challenges in achieving complete eradication.